Хайлтын үр дүнгүүд - Todd VanArsdale
- 20-н 1 - 20 үр дүнгүүдийг харуулж байна
-
1
-
2
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma -н Anthony M. Robinson, Richa Rathore, Nathan Redlich, Douglas R. Adkins, Todd VanArsdale, Brian A. Van Tine, Loren S. Michel
Хэвлэсэн 2019Artigo -
3
Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB -н Todd VanArsdale, Sammee VanArsdale, Walker R. Force, Barbara Walter, George Mosialos, Elliott Kieff, John C. Reed, Carl F. Ware
Хэвлэсэн 1997Artigo -
4
Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. -н Carl F. Ware, Paul D. Crowe, Todd VanArsdale, J. Andrews, M H Grayson, R Jerzy, Craig A. Smith, Raymond G. Goodwin
Хэвлэсэн 1991Artigo -
5
-
6
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor -н Mitsuru Matsumoto, Tsai‐Yuan Hsieh, Nongliao Zhu, Todd VanArsdale, Soon B. Hwang, King-Song Jeng, Alexander E. Gorbalenya, Shih‐Yen Lo, J H Ou, Carl F. Ware, M M Lai
Хэвлэсэн 1997Artigo -
7
TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction -н Xin Ye, Patrick Mehlen, Shahrooz Rabizadeh, Todd VanArsdale, Heying Zhang, Hwain Shin, James J.‐L. Wang, Eugen Leo, Juan M. Zapata, Craig A. Hauser, John C. Reed, Dale E. Bredesen
Хэвлэсэн 1999Artigo -
8
Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model -н Shihao Chen, Li‐Fen Lee, Timothy S. Fisher, Bart Jessen, Mark Elliott, Winston Evering, Kathryn Logronio, Guang Huan Tu, Konstantinos Tsaparikos, Xiaoai Li, Hui Wang, Ying Chi, Mengli Xiong, Todd VanArsdale, John Lin
Хэвлэсэн 2014Artigo -
9
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance -н Ping Chen, Nathan V. Lee, Wenyue Hu, Meirong Xu, Rose Ann Ferre, Hieu Lam, Simon Bergqvist, James Solowiej, Wade Diehl, You-Ai He, Xiu Yu, Asako Nagata, Todd VanArsdale, Brion W. Murray
Хэвлэсэн 2016Artigo -
10
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma -н Beatriz Salvador-Barberó, Mónica Álvarez‐Fernández, Elisabet Zapatero‐Solana, Aicha El Bakkali, Camino Menéndez, Pedro P. López‐Casas, Tomás Di Domenico, Tao Xie, Todd VanArsdale, David J. Shields, Manuel Hidalgo, Marcos Malumbres
Хэвлэсэн 2020Artigo -
11
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia -н Chen Zhao, Alan Chen, Catriona Jamieson, Mark Fereshteh, Annelie Abrahamsson, Jordan Blum, Hyog Young Kwon, Juyong Brian Kim, John P. Chute, David A. Rizzieri, Michael J. Munchhof, Todd VanArsdale, Philip A. Beachy, Tannishtha Reya
Хэвлэсэн 2009Artigo -
12
Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors -н Zhengyan Kan, Ji Wen, Vinícius Bonato, Jennifer Webster, Wenjing Yang, Ivanov Vv, Kimberly H. Kim, Whijae Roh, Chaoting Liu, Xinmeng Jasmine Mu, Jennifer Lapira-Miller, Jon A. Oyer, Todd VanArsdale, Paul A. Rejto, Jadwiga Biénkowska
Хэвлэсэн 2025Artigo -
13
Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1 -н Kevin Ryan, Ben Bolaños, Marissa L. Smith, Prakash B. Palde, Paulina Delgado Cuenca, Todd VanArsdale, Sherry Niessen, Lianglin Zhang, Douglas C. Behenna, Martha A. Ornelas, Khanh Tran, Stephen E. Kaiser, Lawrence Lum, Al Stewart, K.S. Gajiwala
Хэвлэсэн 2020Artigo -
14
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer -н Mónica Álvarez‐Fernández, María Sanz‐Flores, Belén Sanz‐Castillo, María Salazar‐Roa, David Partida, Elisabet Zapatero‐Solana, H. Raza Ali, Eusebio Manchado, Scott W. Lowe, Todd VanArsdale, David J. Shields, Carlos Caldas, Miguel Quintela‐Fandino, Marcos Malumbres
Хэвлэсэн 2017Artigo -
15
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer -н Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley, Koleen Eisele, Todd VanArsdale, Stephen G. Dann, Kim Arndt, Tina Primeau, Elizabeth Griffin, Jieya Shao, Robert G. Crowder, Jinping Lai, John D. Norris, Donald P. McDonnell, Shunqiang Li
Хэвлэсэн 2015Artigo -
16
PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity -н Cathy C. Zhang, Zhengming Yan, Qin Zhang, Kyle Kuszpit, Kenneth Zasadny, Ming Qiu, Cory L. Painter, Anthony Wong, Eugenia Kraynov, Maria E. Arango, Pramod P. Mehta, Ian Popoff, Gerald F. Casperson, Gerrit Los, Steve Bender, Kenna Anderes, James G. Christensen, Todd VanArsdale
Хэвлэсэн 2010Artigo -
17
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity -н Mansi Arora, Justin Moser, Timothy E. Hoffman, Lotte P. Watts, Mingwei Min, Mónica Musteanu, Rong Yao, C. Ryland Ill, Varuna Nangia, Jordan Schneider, Manuel Sanclemente, John D. Lapek, Lisa Nguyen, Sherry Niessen, Stephen Dann, Todd VanArsdale, Mariano Barbacid, Nichol Miller, Sabrina L. Spencer
Хэвлэсэн 2023Artigo -
18
A versatile drug delivery system targeting senescent cells -н Daniel Muñoz‐Espín, Miguel Rovira, Irene Galiana, Cristina Giménez, Beatriz Lozano‐Torres, Marta Pàez‐Ribes, Susana Llanos, Selim Chaib, Maribel Muñoz‐Martín, Álvaro C. Ucero, Guillermo Garaulet, Francisca Mulero, Stephen G. Dann, Todd VanArsdale, David J. Shields, Andrea Bernardos, José Ramón Murguía, Ramón Martínez‐Máñez, Manuel Serrano
Хэвлэсэн 2018Artigo -
19
GLI2 inhibition abrogates human leukemia stem cell dormancy -н Anil Sadarangani, Gabriel Pineda, Kathleen M. Lennon, Hye-Jung Chun, Alice Shih, Annelie Schairer, Angela C. Court, Daniel Goff, Sacha Prashad, Ifat Geron, Russell Wall, John D. McPherson, Richard A. Moore, Minya Pu, Lei Bao, Amy Jackson-Fisher, Michael J. Munchhof, Todd VanArsdale, Tannishtha Reya, Sheldon Morris, Mark D. Minden, Karen Messer, Hanna Mikkola, Marco A. Marra, Thomas J. Hudson, Catriona Jamieson
Хэвлэсэн 2015Artigo -
20
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety -н Cynthia L. Palmer, Britton Boras, Bernadette Pascual, Na Li, Danan Li, Scott J. Garza, Nanni Huser, Jing Yuan, Julie Cianfrogna, Tae Sung, Elizabeth A. McMillan, Na Wei, Jason Carmody, Augustine Kang, Seth Darensburg, Tiana Dodd, James V. Oakley, James Solowiej, Lisa Nguyen, Suvi T. M. Orr, Ping Chen, Eric W. Johnson, Xiu Yu, Wade Diehl, Gary M. Gallego, Mehran Jalaie, Rose Ann Ferre, Sujin Cho-Schultz, Hong Shen, Judith G. Deal, Qin Zhang, Timothy R. Baffi, Meirong Xu, Whijae Roh, Jennifer Lapira-Miller, Jérôme Goudeau, Yanke Yu, Rajat Gupta, Kimberly H. Kim, Stephen G. Dann, Zhengyan Kan, John C. Kath, Sajiv K. Nair, Nichol Miller, Brion W. Murray, Andrew R. Nager, Casey L. Quinlan, Matthew D. Petroski, Cathy Zhang, Aida Sacaan, Todd VanArsdale, Lars Anders
Хэвлэсэн 2025Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Biology
Cancer research
Cell biology
Biochemistry
Genetics
Medicine
Cancer
Immunology
Pharmacology
Internal medicine
Molecular biology
Apoptosis
Cell cycle
Chemistry
In vitro
Receptor
Signal transduction
Tumor necrosis factor alpha
Breast cancer
Computational biology
Cyclin-dependent kinase
Cytotoxic T cell
Lymphotoxin
Lymphotoxin beta receptor
Bioinformatics
CD8
Cancer cell
Cell
Chemotherapy
Drug